Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Pharmacology|March 15, 2012
Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in miceRudolf Schicho, Martin StorrExpert Review of Clinical Pharmacology|November 25, 2011
Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategiesRudolf Schicho, Martin StorrPharmacology|December 21, 2013
Cannabis finds its way into treatment of Crohn's diseaseRudolf Schicho, Martin StorrCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 31, 2011
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesRudolf Schicho, Martin StorrCurrent Opinion in Pharmacology|October 16, 2012
A potential role for GPR55 in gastrointestinal functionsRudolf Schicho, Martin StorrExpert Review of Gastroenterology & Hepatology|March 10, 2017
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Carina Hasenoehrl, Martin Storr, Rudolf SchichoCurrent Drug Targets|February 3, 2015
Cardiovascular complications in inflammatory bowel diseaseRudolf Schicho, Gunther Marsche, Martin StorrClinical and Translational Gastroenterology|January 4, 2020
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel DiseasesMelanie Kienzl, Martin Storr, Rudolf SchichoPharmacology|July 4, 2015
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An OverviewTheodor Bokic, Martin Storr, Rudolf SchichoCurrent Opinion in Gastroenterology|April 30, 2013
Metabolomics: is it useful for inflammatory bowel diseases?Martin Storr, Hans J Vogel, Rudolf SchichoPageof 17